Lipid Droplet Microarrays
Drug Screening Microarrays for High-Throughput screening
Lipid Droplet Microarray Technology (LiMiT) allows tens of thousands of chemical compounds to be screened against cells using a single microscope slide or cell culture plate. Drugs are encapsulated in nanoscopic lipid droplets on the surface of a microscope slide. Cells are then cultured over array, take up the drugs, and then imaged to detect hits. LiMiT Drug Screening Microarrays may reduce the cost of small molecule HTS by over 90%.
Functional Precision Medicine
Lionheart Biotechnology will use LiMiT to test tens of thousands of combinations of anti-cancer drugs on patient derived tumor samples in order to rapidly and accurately predict a patient's response.
Biosensing
Biosensing microarrays can detect and measure thousands of analytes in just a small biological sample. Lionheart is expanding the capabilities of our biosensing microarrays for use in diagnostic medicine.
F.A.Q.
Learn more about Lionheart
Low Reagent Usage
Using drug screening microarrays allows you to cut test compound usage by over 99%.
Cost Savings
Drug screening microarrays offer a 90% decrease in the costs associated with drug discovery due to low reagent usage.
Miniaturization
Taking the microarray route allows researchers to conduct ultra high-throughput screening in small laboratories. No need for bulky fluid handling robots and lab automation equipment. Just populate the microarrays with cells and image to detect hits.
Brick Dust Compounds
Lipid Droplet Microarray Technology allows you to screen water insoluble drugs against cells.
Schedule a call with us to start using LiMiT to support your drug discovery pipeline.
Lionheart is positioned to offer an ultra-high throughput screening service by 2024.